Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £20.17m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

AGM Statement

15 Jun 2018 07:00

RNS Number : 4815R
Inspiration Healthcare Group PLC
15 June 2018
 

15 June 2018

 

Inspiration Healthcare Group plc

Inspiration Healthcare Group plc ("Inspiration Healthcare", the "Company" or the "Group")

 

 

AGM statement

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, will hold its Annual General Meeting at 11.30am today and the Chairman, Mr Mark Abrahams, will give the following statement to shareholders:

 

"We were delighted to post revenues of £15.5m for the year ended 31 January 2018 and deliver the Group's fifteenth consecutive year of revenue growth. Additionally, we recorded an Operating Profit of £1.2m, slightly ahead of expectations. All of which was achieved in an evolving and increasingly challenging medical devices regulatory environment.

 

Our plans to launch new products in the current financial year have been frustrated by the significant delays we have experienced in obtaining an updated Quality Management System certificate and a CE Mark approval for our upgraded Patient Warming System from our Notified Body.

 

In the last 48 hours, and much later than we expected, we received these two certificates and we will now endeavour to make up for lost time and minimise the impact of the delay through putting in place a number of cost saving measures across the Group. We remain confident that the projected full year operating result remains achievable and expect Group revenues will be weighted towards the second half of the financial year.

 

 

Last week it was announced by NeuroproteXeon Limited ("NPXe"), a company in which Inspiration Healthcare holds 10% of the current issued share capital (or 8.1% diluted for options in existence at the time of the announcement), that NPXe confirms that it is seeking to complete an IPO on AIM in the second half of 2018. We will continue to monitor developments with interest and will update shareholders accordingly."

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

Tel: 07771 713608

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

 

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

 

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUSAKRWWANAAR
Date   Source Headline
25th Oct 202110:15 amRNSReplacement: Director/PDMR Shareholding
22nd Oct 20214:35 pmRNSDirector/PDMR Shareholding
20th Oct 20215:02 pmRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSInterim Results
4th Oct 20217:00 amRNSTR1 Notification
24th Sep 20217:00 amRNSNotice of Results, Mello and AIM Awards
11th Aug 20217:00 amRNSTrading Update
27th Jul 202110:13 amRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSTR1 Notification
25th Jun 202112:43 pmRNSResult of AGM
25th Jun 20217:00 amRNSAGM Statement
23rd Jun 20211:15 pmRNSAGM Notice
22nd Jun 20217:00 amRNSProject WAVE recruits first patient
16th Jun 20219:18 amRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSCapital Markets Day
28th May 20217:00 amRNSAnnual Report 2021 and Notice of AGM
20th May 20212:15 pmRNSMello Healthcare Presentation 25th May 2021
17th May 20217:00 amRNS£1.25m Ventilator Order received from China
29th Apr 20217:00 amRNSQueen’s Award for Enterprise for SLE Ltd
29th Apr 20217:00 amRNSTR1 Notification
27th Apr 20217:00 amRNSFinal Results
21st Apr 20217:00 amRNSSLE 6000 & OxyGenie® China approval &250k Order
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
29th Mar 20217:00 amRNSDistribution Agreement and MoU
16th Mar 20217:00 amRNSSLE 6000 & OxyGenie® Japan approval & £400k Order
23rd Feb 20212:10 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:01 pmRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn
23rd Feb 202111:01 amRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSResults date and post period end update
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Feb 20212:06 pmRNSSecond Price Monitoring Extn
15th Feb 20212:00 pmRNSPrice Monitoring Extension
15th Feb 202111:06 amRNSSecond Price Monitoring Extn
15th Feb 202111:01 amRNSPrice Monitoring Extension
15th Feb 20219:06 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:01 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSRevenue and Profit Upgrade
21st Jan 20217:00 amRNSExercise of options and Total Voting Rights
14th Jan 20217:00 amRNSTR1 Notification
2nd Dec 20207:00 amRNSEuropean Patent granted for Project WAVE
1st Dec 20201:16 pmRNSInspiration wins AIM Transaction of the Year Award
16th Nov 20207:00 amRNSProject WAVE MHRA Approval
29th Oct 20207:00 amRNSAppointment of Non-Executive Director
6th Oct 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.